James Li, MD
Vascular Surgery · Odessa, TXNPI 1932184629
Payments from drug & device makers
What this record shows
This record is dominated by other: $28,219 of the $33,022 with a category attached, or 85.5%. Angiodynamics, Inc. accounts for 71.3% of it on its own, with 27 other manufacturers making up the rest. Reporting peaked in 2023 at $25,599 and has fallen 97.7% since, to $600 in 2025.
Across 167 payments — averaging $197.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Angiodynamics, Inc.$24K
- Medtronic$5K
- W. L. Gore & Associates, Inc.$2K
- Boston Scientific$962
- Bard Peripheral Vascular, Inc.$334
- Philips North America LLC$331
- plus $1K from 22 others
What the payments were for
- Travel & lodging$1,1123%
- Food & beverage$3,69111%
- Other$28,21985%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Angiodynamics, Inc. | 4 | $23,561 |
| Medtronic | 9 | $4,892 |
| W. L. Gore & Associates, Inc. | 21 | $1,511 |
| Boston Scientific | 57 | $962 |
| Bard Peripheral Vascular, Inc. | 6 | $334 |
| Philips North America LLC | 11 | $331 |
| Endologix LLC | 1 | $305 |
| Penumbra, Inc. | 6 | $163 |
| Silk Road Medical, Inc. | 7 | $138 |
| Cook Medical LLC | 10 | $120 |
| Cardiovascular Systems Inc. | 5 | $88 |
| Tactile Systems Technology Inc | 4 | $87 |
| Cordis US CORP. | 4 | $77 |
| Bioventus LLC | 4 | $62 |
| BD | 1 | $53 |
| Apellis Pharmaceuticals, Inc. | 1 | $48 |
| Abbott | 3 | $47 |
| Acell, Inc. | 2 | $36 |
| Siemens Medical Solutions USA, Inc. | 2 | $31 |
| Smith+Nephew | 1 | $24 |
| Lemaitre Vascular, Inc. | 1 | $24 |
| Artivion, Inc. | 1 | $23 |
| Johnson & Johnson | 1 | $23 |
| Laminate Medical Technologies Inc. | 1 | $22 |
| Inari Medical, Inc. | 1 | $19 |
| Getinge USA Sales, LLC | 1 | $18 |
| Globus Medical | 1 | $16 |
| Lifenet Health | 1 | $8 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$33,022 in reported general payments places this provider in the 80th percentile of 347 vascular surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 140 | $102,220 |
| ClopidogrelClopidogrel Bisulfate | 204 | $1,146 |
| Cilostazol | 41 | $377 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 50 | $374 |
| Tramadol Hcl | 19 | $45 |
| Prednisone | 31 | $29 |
Paid to pharmacies, not to this prescriber.
Other vascular surgery in Odessa
- Gregory PearlDallas$2.3M
- Mazin FotehAustin$1.6M
- Alan LumsdenHouston$742K
- Stephen HohmannDallas$499K
- Michael SiahDallas$392K
- Gustavo OderichHouston$319K
- Jean BismuthHouston$243K
- Carlos TimaranDallas$231K
- Dennis GableDallas$211K
- Thomas LohShenandoah$201K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.